Cargando…
Systemic Therapy In Acquired Haemophilia – A Single Institute Experience
A cornerstone of the management of Acquired Haemophilia A (AHA) involves inhibitor eradication. First line immunosuppressive agents are usually steroids, either alone or in combination with cyclophosphamide. We present the use of Rituximab, cyclophosphamide, vincristine and prednisolone (RCVP) combi...
Autores principales: | Sarah, Lawless, Prantik, Das, Gary, Benson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Ulster Medical Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031107/ https://www.ncbi.nlm.nih.gov/pubmed/27698522 |
Ejemplares similares
-
Hæmophilia
Publicado: (1905) -
Acquired Haemophilia A: An Intriguing Disease
por: Mazzucconi, Maria Gabriella, et al.
Publicado: (2020) -
Acquired Haemophilia Associated with Urticarial Vasculitis
por: Attout, Hassene
Publicado: (2020) -
Acquired Haemophilia A: A 15-Year Single-Centre Experience of Demography, Clinical Features and Outcome
por: Guerrero Camacho, Raisa, et al.
Publicado: (2022) -
Haemophilia in the developing countries: the Iranian experience
por: Eshghi, Peyman, et al.
Publicado: (2010)